Jade Biosciences, Inc. Common Stock JBIO Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $55.09M-37.7% | $88.44M+76.5% | $50.11M-77.3% | $220.94M+400% | $44.22M-36.3% | ||
| $256.21M+3.4% | $247.72M+66.5% | $148.8M— | —— | $31.99M— | ||
| $318.52M-8.7% | $348.82M+73.2% | $201.36M-9.7% | $222.98M+188% | $77.37M+11.1% | ||
| $157K-7.6% | $170K-3.4% | $176K+19.7% | $147K+7,250% | $2K— | ||
| $319.43M-8.7% | $349.78M+72.8% | $202.45M-9.6% | $223.97M+189% | $77.53M+6.5% | ||
| $3.98M+85.0% | $2.15M+59.3% | $1.35M-82.2% | $7.59M+10,894% | $69K-94.7% | ||
| $22.29M+34.8% | $16.54M-26.0% | $22.36M+3.4% | $21.62M+794% | $2.42M-79.9% | ||
| $22.97M+33.1% | $17.26M-25.3% | $23.1M+3.1% | $22.41M+801% | $2.49M-97.9% | ||
| $5K0.0% | $5K+66.7% | $3K0.0% | $3K0.0% | $3K+200% | ||
| -$214.76M-23.1% | -$174.39M-22.4% | -$142.46M-21.5% | -$117.28M+50.2% | -$235.57M-401% | ||
| $296.46M-10.8% | $332.52M+85.4% | $179.35M-11.0% | $201.56M+341% | -$83.51M-78.4% | ||
| $319.43M-8.7% | $349.78M+72.8% | $202.45M-9.6% | $223.97M+189% | $77.53M+6.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Jade Biosciences, Inc. Common Stock's total assets?
- Jade Biosciences, Inc. Common Stock (JBIO) holds $319.4M in total assets, up 312.0% year over year.
- How much debt does Jade Biosciences, Inc. Common Stock have?
- Jade Biosciences, Inc. Common Stock carries $808.0K in total debt against $296.5M of shareholders' equity, a debt-to-equity ratio of 0.00.
- How much cash does Jade Biosciences, Inc. Common Stock have?
- Jade Biosciences, Inc. Common Stock holds $55.1M in cash and equivalents.
- Can Jade Biosciences, Inc. Common Stock cover its short-term obligations?
- Its current ratio is 14.29 — current assets exceed current liabilities.
- Where does Jade Biosciences, Inc. Common Stock's balance sheet data come from?
- Every line is extracted from Jade Biosciences, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.